Zimmer Biomet Holdings (ZBH) FY2024 results: revenue $7.7 billion, up 3.8% on the year
Zimmer Biomet Holdings, Inc. (ZBH) reported revenue of $7.7 billion for fiscal 2024, the year ended 31 December 2024, up 3.8% on the year before. Net income was $904 million, down 11.7%, and diluted earnings per share $4.43. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2025.
Revenue
$7.7 billion
+3.8% on the year
FY2017FY2024
Operating margin
16.7%
17.3% a year earlier
FY2017FY2024
Net income
$904 million
-11.7% on the year
FY2017FY2024
Diluted EPS
$4.43
-9.2% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
1,499
1,582
1,285
-5.2%
Capital expenditure
204
291
188
-30.0%
Free cash flow
1,296
1,290
1,097
+0.4%
Free cash flow margin
16.9%
17.5%
15.8%
Cash from investing
-888
-779
n/a
Cash from financing
-484
-764
n/a
Depreciation and amortisation
996
952
926
+4.7%
Share-based compensation
101
99.8
105
+1.2%
Buybacks
868
692
126
+25.4%
Dividends paid
196
201
201
-2.4%
Dividend per share
$0.96
$0.96
$0.96
0.0%
Diluted shares, weighted
204m
210m
210m
-2.8%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
12,468
12,480
12,020
-0.1%
Non-controlling interest
8.1
7.7
6.7
+5.2%
Debt
6,205
5,800
5,700
+7.0%
Operating lease liabilities
190
174
167
+9.1%
Other liabilities
2,494
3,034
3,172
-17.8%
Total liabilities and equity
21,365
21,497
21,066
-0.6%
Fixed assets
2,049
2,060
1,872
-0.6%
Goodwill
8,951
8,818
8,580
+1.5%
Intangible assets
4,598
4,856
5,064
-5.3%
Cash and equivalents
526
416
376
+26.4%
Receivables
1,481
1,442
1,382
+2.7%
Inventory
2,235
2,385
2,147
-6.3%
Other assets
1,526
1,518
1,645
+0.5%
Total assets
21,365
21,497
21,066
-0.6%
10-K for the year ended 31 December 2024, filed 25 February 2025: the filing.